의약품 포장 시장 규모, 점유율, 동향 분석 보고서 : 재료별, 제품별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

Pharmaceutical Packaging Market Summary

The global pharmaceutical packaging market size was estimated at USD 166.38 billion in 2025 and is expected to reach USD 353.09 billion, growing at a CAGR of 9.9% from 2026 to 2033. The enormous growth of the pharmaceutical sector is one of the primary growth factors for the pharmaceutical packaging sector.

The pharmaceutical business has been expanding quickly in recent years due to scientific and technological advancements, and this trend is predicted to continue over the projection period, particularly in developing nations like China, India, Saudi Arabia, and Brazil. Continuous advancements in medical science and bioscience fundamentally drive the pharmaceutical industry. In Europe, the sector represents a critical pillar of the regional economy, ranking among the continent's top-performing high-technology industries. Over the past few years, the pharmaceutical landscape has undergone a significant transition, marked by a growing emphasis on biopharmaceutical and biotechnology-driven therapies. Many of these advanced drug formulations exhibit limited stability in liquid form and are therefore commercialized as lyophilized or dry-powder dosage forms. Such products require highly specialized packaging solutions to preserve efficacy, sterility, and shelf life, thereby creating substantial growth opportunities for pharmaceutical packaging manufacturers.

Pharmaceutical drugs are predominantly marketed in tablet, capsule, liquid, and powder formats, each requiring distinct packaging approaches. Common packaging types include rigid bottles, stand-up pouches, flat pouches, sachets, and blister packs. To meet evolving regulatory standards and patient expectations, packaging companies are increasingly incorporating advanced features such as dispensing mechanisms, administration aids, sustainable materials, tamper-evident designs, and anti-counterfeiting technologies. These functional enhancements not only improve patient safety and convenience but also support brand differentiation in a highly regulated market.

Sustainability has emerged as a key strategic focus within pharmaceutical packaging. Manufacturers are increasingly adopting post-consumer recycled (PCR) materials and developing packaging solutions using compostable and bio-based materials to reduce environmental impact. For instance, Gerresheimer AG, a leading pharmaceutical packaging provider, has been offering glass bottles made from PCR glass for several years and has expanded its portfolio to include bottles manufactured from recycled PET (R-PET) and bio-based PET (BIO-PET) derived from sugarcane. This shift toward sustainable packaging is expected to accelerate significantly in the coming years, driven by regulatory pressure and corporate sustainability commitments.

In addition, the development of intelligent and connected packaging represents a major opportunity for the pharmaceutical industry. Smart packaging solutions integrated with Internet of Things (IoT) technologies enable real-time monitoring of critical parameters such as temperature, humidity, and handling conditions, thereby ensuring product integrity throughout storage and transportation. Furthermore, the rising adoption of personalized medicine and specialty drugs is driving demand for customized packaging solutions tailored to specific dosages and administration requirements. Pharmaceutical packaging companies that successfully align with these technological, regulatory, and sustainability trends are likely to gain a competitive advantage and achieve sustained growth in an increasingly dynamic market.

Global Pharmaceutical Packaging Market Report Segmentation

This report forecasts revenue growth at a global level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global pharmaceutical packaging market report based on product, material, end use, and region:

• Material Outlook (Revenue, USD Million, 2021 - 2033)
• Plastics & Polymers
  • Polyvinyl Chloride (PVC)
  • Polypropylene (PP)
  • Homo
  • Random
  • Polyethylene Terephthalate (PET)
  • Polyethylene (PE)
  • HDPE
  • LDPE
  • LLDPE
  • Polystyrene (PS)
  • Others
• Paper & Paperboard
• Glass
• Aluminium Foil
• Others
• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Primary
  • Plastic Bottles
  • Caps & Closures
  • Parenteral Containers
  • Syringes
  • Vials & Ampoules
  • Others
  • Blister Packs
  • Prefillable Inhalers
  • Pouches
  • Medication Tubes
  • Others
• Secondary
  • Prescription Containers
  • Pharmaceutical Packaging Accessories
• Tertiary
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Pharma Manufacturing
• Contract Packaging
• Retail Pharmacy
• Institutional Pharmacy
• Region Outlook (Revenue, USD Million 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Turkey
• Asia Pacific
  • China
  • India
  • Japan
  • South East Asia
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • Egypt
  • GCC

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Research Methodology
  • 1.1.1. Market Segmentation
  • 1.1.2. Market Definition
• 1.2. Research Scope & Assumptions
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources & Third-Party Perspectives
  • 1.3.4. Primary Research
• 1.4. Information Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Data Visualization
• 1.6. Data Validation & Publishing
• 1.7. List of Abbreviations

Chapter 2. Executive Summary

• 2.1. Market Snapshot, 2025 (USD Million)
• 2.2. Segmental Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Global Pharmaceutical Packaging Market Variables, Trends, and Scope

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Industry Value Chain Analysis
  • 3.3.1. Raw Material Trends
  • 3.3.2. Profit Margin Analysis
  • 3.3.3. Price Trend Analysis
    • 3.3.3.1. Factors Affecting the Pricing Deviation
• 3.5. Regulatory Framework
• 3.6. Market Dynamics
  • 3.6.1. Market Driver Analysis
  • 3.6.2. Market Restraint Analysis
  • 3.6.3. Market Opportunity Analysis
  • 3.6.4. Market Challenge Analysis
• 3.7. Business Environment Analysis
  • 3.7.1. Porter's Five Forces Analysis
  • 3.7.2. PESTEL Analysis
• 3.8. Unmet Needs & Challenges in Pharmaceutical Packaging Industry
• 3.9. Impact of Environmental, Social, and Governance (ESG) initiatives on the Pharmaceutical Packaging Market

Chapter 4. Global Pharmaceutical Packaging Market: Material Estimates & Trend Analysis

• 4.1. Key Takeaways
• 4.2. Material Movement Analysis & Market Share, 2025 & 2033
  • 4.2.1. Plastics & Polymers
    • 4.2.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.2.1.2. Polyvinyl Chloride (PVC)
    • 4.2.1.3. Polypropylene (PP)
      • 4.2.1.3.1. Homo
      • 4.2.1.3.2. Random
    • 4.2.1.4. Polyethylene Terephthalate (PET)
    • 4.2.1.5. Polyethylene (PE)
      • 4.2.1.5.1. HDPE
      • 4.2.1.5.2. LDPE
      • 4.2.1.5.3. LLDPE
    • 4.2.1.6. Polystyrene (PS)
    • 4.2.1.7. Others
  • 4.2.2. Paper & Paperboard
    • 4.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.2.3. Glass
    • 4.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.2.4. Aluminium Foil
    • 4.2.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.2.5. Others
    • 4.2.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Global Pharmaceutical Packaging Market: Product Estimates & Trend Analysis

• 5.1. Key Takeaways
• 5.2. Product Movement Analysis & Market Share, 2025 & 2033
  • 5.2.1. Primary
    • 5.2.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.2.1.2. Plastic Bottles
    • 5.2.1.3. Caps & Closures
    • 5.2.1.4. Parenteral Containers
      • 5.2.1.4.1. Syringes
      • 5.2.1.4.2. Vials & Ampoules
      • 5.2.1.4.3. Others
    • 5.2.1.5. Blister Packs
    • 5.2.1.6. Prefillable Inhalers
    • 5.2.1.7. Pouches
    • 5.2.1.8. Medication Tubes
    • 5.2.1.9. Others
  • 5.2.2. Secondary
    • 5.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.2.2.2. Prescription Containers
    • 5.2.2.3. Pharmaceutical Packaging Accessories
  • 5.2.3. Tertiary
    • 5.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Global Pharmaceutical Packaging Market: End Use Estimates & Trend Analysis

• 6.1. Key Takeaways
• 6.2. End Use Movement Analysis & Market Share, 2025 & 2033
  • 6.2.1. Pharma Manufacturing
    • 6.2.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.2.2. Contract Packaging
    • 6.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.2.3. Retail Pharmacy
    • 6.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.2.4. Institutional Pharmacy
    • 6.2.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Global Pharmaceutical Packaging Market: Region Estimates & Trend Analysis

• 7.1. Key Takeaways
• 7.2. Regional Movement Analysis & Market Share, 2025 & 2033
• 7.3. North America
  • 7.3.1. North America Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. U.S. Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Canada Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Mexico Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Germany Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 7.4.3. UK
    • 7.4.3.1. UK Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. France Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Italy Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Spain Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 7.4.7. Turkey
    • 7.4.7.1. Turkey Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 7.4.8. Russia
    • 7.4.8.1. Russia Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. China Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 7.5.3. India
    • 7.5.3.1. India Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 7.5.4. Japan
    • 7.5.4.1. Japan Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. South Korea Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 7.5.6. South East Asia
    • 7.5.6.1. South East Asia Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Brazil Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Argentina Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million)
• 7.7. Middle East & Africa
  • 7.7.1. Middle East & Africa Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 7.7.2. Egypt
    • 7.7.2.1. Egypt Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 7.7.3. GCC Countries

Chapter 8. Competitive Landscape

• 8.1. Key Global Players & Recent Developments & Their Impact on the Industry
• 8.2. Vendor Landscape
  • 8.2.1. Company Categorization
  • 8.2.2. List of key Raw Material Distributors and Channel Partners
  • 8.2.3. List of Potential Customers/End-Users
• 8.3. Competitive Dynamics
  • 8.3.1. Company Market Position Analysis
  • 8.3.2. Company Heat Map Analysis
• 8.4. Strategy Mapping
  • 8.4.1. Expansions
  • 8.4.2. Mergers & Acquisitions
  • 8.4.3. Collaborations
  • 8.4.4. New Product Launches
  • 8.4.5. Others

Chapter 9. Company Listing (Overview, Financial Performance, Product Overview)

• 9.1. Amcor plc
  • 9.1.1. Company Overview
  • 9.1.2. Financial Performance
  • 9.1.3. Product Benchmarking
• 9.2. Becton, Dickinson, and Company
  • 9.2.1. Company Overview
  • 9.2.2. Financial Performance
  • 9.2.3. Product Benchmarking
• 9.3. AptarGroup, Inc.
  • 9.3.1. Company Overview
  • 9.3.2. Financial Performance
  • 9.3.3. Product Benchmarking
• 9.4. Drug Plastics Group
  • 9.4.1. Company Overview
  • 9.4.2. Financial Performance
  • 9.4.3. Product Benchmarking
• 9.5. Gerresheimer AG
  • 9.5.1. Company Overview
  • 9.5.2. Financial Performance
  • 9.5.3. Product Benchmarking
• 9.6. Schott AG
  • 9.6.1. Company Overview
  • 9.6.2. Financial Performance
  • 9.6.3. Product Benchmarking
• 9.7. Owens Illinois, Inc.
  • 9.7.1. Company Overview
  • 9.7.2. Financial Performance
  • 9.7.3. Product Benchmarking
• 9.8. West Pharmaceutical Services, Inc.
  • 9.8.1. Company Overview
  • 9.8.2. Financial Performance
  • 9.8.3. Product Benchmarking
• 9.9. Berry Global, Inc.
  • 9.9.1. Company Overview
  • 9.9.2. Financial Performance
  • 9.9.3. Product Benchmarking
• 9.10. WestRock Company
  • 9.10.1. Company Overview
  • 9.10.2. Financial Performance
  • 9.10.3. Product Benchmarking
• 9.11. SGD Pharma
  • 9.11.1. Company Overview
  • 9.11.2. Financial Performance
  • 9.11.3. Product Benchmarking
• 9.12. International Paper
  • 9.12.1. Company Overview
  • 9.12.2. Financial Performance
  • 9.12.3. Product Benchmarking
• 9.13. Comar, LLC
  • 9.13.1. Company Overview
  • 9.13.2. Financial Performance
  • 9.13.3. Product Benchmarking
• 9.14. CCL Industries, Inc.
  • 9.14.1. Company Overview
  • 9.14.2. Financial Performance
  • 9.14.3. Product Benchmarking
• 9.15. Vetter Pharma International
  • 9.15.1. Company Overview
  • 9.15.2. Financial Performance
  • 9.15.3. Product Benchmarking